PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'PCND Neuroscience Research Institute, Poway, CA, USA.\', \'Tokyo Metropolitan Institute of Medical Science, 2-1-6 Kamikitazawa, Setagaya-ku, Tokyo, Japan.\', \'Division of Neurosciences, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA.\', \'Tokyo Metropolitan Institute of Medical Science, 2-1-6 Kamikitazawa, Setagaya-ku, Tokyo, Japan. Electronic address: hashimoto-mk@igakuken.or.jp.\']
?:citedBy
  • -1
?:creator
?:doi
  • S1359-6446(21)00149-510.1016/j.drudis.2021.03.013
?:doi
?:hasPublicationType
?:journal
  • Drug discovery today
is ?:pmid of
?:pmid
?:pmid
  • 33775925
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.008
?:rankingScore_hIndex
  • 150
is ?:relation_isRelatedTo_publication of
?:title
  • Diabetes, inflammation, and the adiponectin paradox: Therapeutic targets in SARS-CoV-2.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33775925>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33775925>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all